Cargando…
Desmopressin acetate use in von Willebrand’s disease: a survey on current practices in Brazil
INTRODUCTION: von Willebrand’s disease (VWD) is the most common inherited bleeding disorder. The 1-desamino-8-d-arginine vasopressin (DDAVP) is the treatment of choice for most responsive patients with VWD. The aim of this study was to evaluate DDAVP use in the management of VWD. METHOD: We implemen...
Autores principales: | Lopes, Maria Sueli da Silva Namen, Rezende, Suely Meireles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910174/ https://www.ncbi.nlm.nih.gov/pubmed/32057765 http://dx.doi.org/10.1016/j.htct.2019.12.004 |
Ejemplares similares
-
Desmopressin testing in von Willebrand disease: Lowering the burden
por: Heijdra, Jessica M., et al.
Publicado: (2022) -
Desmopressin responsiveness by age in type 1 von Willebrand disease
por: Goldberg, Nicola, et al.
Publicado: (2020) -
Desmopressin as a Treatment in Patients With Von Willebrand Disease: A Systematic Review
por: Beltran, Andres, et al.
Publicado: (2023) -
Venous thromboembolism in COVID-19 and inherited thrombophilia
por: Medina, Ester Martins Camillozzi, et al.
Publicado: (2022) -
Desmopressin Acetate in Intracranial Haemorrhage
por: Kapapa, Thomas, et al.
Publicado: (2014)